Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 502-518
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Figure 3 Jianpi Gushen Huayu Decoction reduced oxidative stress and inflammation in kidneys.
A: The activities of superoxide dismutase; B: The activities of glutathione peroxidase; C: Malondialdehyde level; D: Interleukin (IL)-6 levels; E: IL-1β levels; F: Tumor necrosis factor-α levels. bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGSL: Low-dose Jianpi Gushen Huayu Decoction; JPGSM: Medium-dose Jianpi Gushen Huayu Decoction; JPGSH: High-dose Jianpi Gushen Huayu Decoction; IRBE: Irbesartan; SOD: Superoxide dismutase; GSH-Px: Glutathione peroxidase; MDA: Malondialdehyde; IL-6: Interleukin 6; IL-1β: Interleukin 1 beta; TNF-α: Tumor necrosis factor alpha.
- Citation: Ma ZA, Wang LX, Zhang H, Li HZ, Dong L, Wang QH, Wang YS, Pan BC, Zhang SF, Cui HT, Lv SQ. Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways. World J Diabetes 2024; 15(3): 502-518
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/502.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.502